ZA202008062B - Pharmaceutically acceptable salts of sepiapterin - Google Patents

Pharmaceutically acceptable salts of sepiapterin

Info

Publication number
ZA202008062B
ZA202008062B ZA2020/08062A ZA202008062A ZA202008062B ZA 202008062 B ZA202008062 B ZA 202008062B ZA 2020/08062 A ZA2020/08062 A ZA 2020/08062A ZA 202008062 A ZA202008062 A ZA 202008062A ZA 202008062 B ZA202008062 B ZA 202008062B
Authority
ZA
South Africa
Prior art keywords
sepiapterin
pharmaceutically acceptable
acceptable salts
salts
pharmaceutically
Prior art date
Application number
ZA2020/08062A
Inventor
E Levy Daniel
Smith Neil
Reis Jonathan
Yoshino Hiroshi
Komoda Taichi
Shiro Yuichi
MURATA Shunichi
Matsumoto Takayoshi
Kishimoto Kaito
Original Assignee
Ptc Therapeutics Mp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/034505 external-priority patent/WO2019232120A1/en
Application filed by Ptc Therapeutics Mp Inc filed Critical Ptc Therapeutics Mp Inc
Publication of ZA202008062B publication Critical patent/ZA202008062B/en

Links

ZA2020/08062A 2018-05-30 2020-12-23 Pharmaceutically acceptable salts of sepiapterin ZA202008062B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862678025P 2018-05-30 2018-05-30
US201862726612P 2018-09-04 2018-09-04
US201962822336P 2019-03-22 2019-03-22
PCT/US2019/034505 WO2019232120A1 (en) 2018-05-30 2019-05-30 Pharmaceutically acceptable salts of sepiapterin

Publications (1)

Publication Number Publication Date
ZA202008062B true ZA202008062B (en) 2023-04-26

Family

ID=86060075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/08062A ZA202008062B (en) 2018-05-30 2020-12-23 Pharmaceutically acceptable salts of sepiapterin

Country Status (1)

Country Link
ZA (1) ZA202008062B (en)

Similar Documents

Publication Publication Date Title
IL279101A (en) Pharmaceutically acceptable salts of sepiapterin
MA39749A (en) Piperidine-dione derivatives
IL247901A0 (en) Addition salts of (s)-2-(1-(6-amino-5-cyanopyrimidin-4-ylamino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[1,2-f][1,2,4]triazine-5-carbonitrile
IL266955B1 (en) Polymorphs of sepiapterin and salts thereof
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
HUE057926T2 (en) Method for the preparation of thiocarbonates
PT3580219T (en) Process for the preparation of remimazolam and solid state forms of remimazolam salts
EP3480198A4 (en) Novel compound or pharmaceutically acceptable salt thereof
EP3705478A4 (en) Triazine compound and pharmaceutically acceptable salt thereof
IL276592A (en) Derivatives of sobetirome
FI3830085T3 (en) Deuterated derivatives of lanifibranor
PT3411378T (en) Crystalline forms of tenofovir alafenamide monofumarate
GB2587172B (en) Pyronaridine or pharmaceutically acceptable salts thereof for the treatment of cancer
EP3650460A4 (en) Polypeptide pharmaceutically acceptable salt et use thereof
HK1221225A1 (en) Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors 35-
ZA202101652B (en) Novel thiazole derivatives and pharmaceutically acceptable salts thereof
ZA202008062B (en) Pharmaceutically acceptable salts of sepiapterin
ZA201900717B (en) Synthesis of (s)-2-amino-4-methyl-1-((r)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
EP3409662A4 (en) Novel compound and pharmaceutically acceptable salt thereof
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
MX2017007510A (en) A process for the manufacture of idalopirdine.
SG11202105355XA (en) Crystalline salts of corydalmine
HUP1800397A2 (en) Process for the preparation of lumateperone and salts thereof
IL278064A (en) Meglumine salts of thienopyrimidines
GB201911873D0 (en) Storage of respiratory produce